Amphastar Pharmaceuticals (AMPH) Change in Taxes (2013 - 2017)

Amphastar Pharmaceuticals has reported Change in Taxes for 5 years, with the latest figure at -$2.5 million in Q3 2017.

• On a quarterly basis, Change in Taxes fell 351.29% year-over-year to -$2.5 million in Q3 2017; TTM through Sep 2017 was -$5.8 million, a 236.88% decrease from a year earlier, with the FY2015 full-year figure at -$92000.0, down 116.46% from the prior year.
• Change in Taxes was -$2.5 million for Q3 2017 at Amphastar Pharmaceuticals, up from -$3.2 million in the prior quarter.
• The five-year high for Change in Taxes was $6.0 million in Q4 2014, with the low at -$5.4 million in Q3 2014.
• Average Change in Taxes over 5 years is -$314500.0, with a median of -$154000.0 recorded in 2014.
• The sharpest annual moves came in 2014 and 2017: Change in Taxes jumped 15137.5% in 2014, then sank 351.29% in 2017.
• Over 5 years, Change in Taxes stood at -$40000.0 in 2013, then surged by 15137.5% to $6.0 million in 2014, then tumbled by 83.52% to $991000.0 in 2015, then slumped by 154.89% to -$544000.0 in 2016, then tumbled by 351.29% to -$2.5 million in 2017.
• The last three Change in Taxes figures came in at -$2.5 million (Q3 2017), -$3.2 million (Q2 2017), and $394000.0 (Q1 2017), per Business Quant data.